🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Investigation of a tear-based, lab-developed biological test for breast can...
Status
Unknown
Location
Namida Lab
Start Date
2021-10-01
Trial ID
NCT05268224
Treatments Being Tested
This Pilot Study is to investigate the tear proteins in a multitude of canc...
Status
Unknown
Location
Namida Lab
Start Date
2021-08-25
Trial ID
NCT05223218
Treatments Being Tested
LacryDiag is a new Conformity European (CE) marked diagnostic imaging devic...
Status
Completed
Location
Chu Saint-Etienne
Start Date
2019-11-14
Trial ID
NCT04093037
Amyotrophic Lateral Sclerosis (ALS) is the most common neurodegenerative di...
Status
Completed
Location
Ophthalmology Department, University Hospital of Tours, France
Start Date
2021-09-17
Trial ID
NCT04953286
The diagnosis of Alzheimer's disease (AD) relies on the detection of protei...
Status
Recruiting
Location
CHRU de Tours
Start Date
2025-07-09
Trial ID
NCT06661564
This is a single-center prospective pilot study involving the ophthalmology...
Status
Completed
Location
University Hospital
Start Date
2023-02-09
Trial ID
NCT05562115
Treatments Being Tested
This study will explore and better understand the value, usage, and benefit...
Status
Unknown
Location
Namida Lab
Start Date
2021-06-01
Trial ID
NCT04928014
Treatments Being Tested
To assess the levels of loteprednol etabonate (LE) in tear fluid following ...
Status
Completed
Location
Bausch & Lomb Research Clinic
Start Date
2013-01
Trial ID
NCT01736527
Treatments Being Tested
Prevalence of HPV-associated eye infection and cytokine levels in tears fro...
Status
Completed
Location
Faculty of medicine, Chulalongkorn university
Start Date
2020-01-01
Trial ID
NCT04117386
The aim of the research was to examine the effect of oral care bundle appli...
Status
Completed
Location
Gül Güneş AKTAN
Start Date
2019-05-01
Trial ID
NCT06258603
Treatments Being Tested